Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ko Okabe"'
Autor:
KO OKABE, NAOKI TERADA, TATSUYA SHIRAKAWA, CHIE ONIZUKA, TOMOYA KIMURA, YASUHIRO YAMASHITA, ISAMU OTUKA, TAKASHI UENO, MASAFUMI NAGANO, HIROKI TAKAMORI, SHOICHIRO MUKAI, TOSHIYUKI KAMOTO
Publikováno v:
Anticancer research. 42(10)
Radium-223 (Ra-223) therapy provides a survival benefit for castration-resistant prostate cancer (CRPC) patients with bone metastasis. The optimal timing of using Ra-223 has not been determined. We evaluated the efficacy and safety of Ra-223 before a
Autor:
Shoichi, Kimura, Naoki, Terada, Isamu, Otsuka, Tomoya, Kimura, Yukiya, Fujisaki, Ko, Okabe, Takahiro, Akioka, Masato, Fujii, Chie, Onizuka, Takeshi, Yamazaki, Kentaro, Kuroiwa, Shoichiro, Mukai, Toshiyuki, Kamoto
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(9)
Miyazaki Urological Cancer Database (MUCD) is a web-based database containing background, treatment, and prognosis of patients with prostate, renal, and urothelial cancers diagnosed in Miyazaki. We entered information on patients diagnosed with uroth
Autor:
Kaoru, Ito, Hiroki, Takamori, Takahiro, Akioka, Takuya, Hida, Ko, Okabe, Kazutaka, Kida, Naoki, Terada, Toshio, Kamimura, Shoichiro, Mukai, Toshiyuki, Kamoto
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(7)
We report a case of Stauffer syndrome-like findings in a patient with metastatic renal carcinoma treated by surgery and molecular targeted therapy. The patient was a 58-year-old woman diagnosed with renal carcinoma with multiple metastases. She had h
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(2)
We evaluated the impact of tumor shrinkage (TS) induced by molecular targeted therapy as the first-line systemic therapy on the survival of patients with metastatic renal cell carcinoma (mRCC). A total of 67 patients with mRCC who received first-line
Autor:
Akio, Takayanagi, Atsushi, Takahashi, Wakako, Yorozuya, Kazutaka, Maruo, Ko, Okabe, Hidetoshi, Tabata, Yoshio, Takagi
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 65(11)
We examined the postoperative urinary continence rate, and preoperative and postoperative factors predicting postoperative urinary continence for patients who underwent robot-assisted laparoscopic radical prostatectomy (RARP) at our hospital. In all,
Autor:
Kohei Hashimoto, Tetsuya Shindo, Naotaka Nishiyama, Hitoshi Tachiki, Ko Okabe, Keisuke Taguchi, Atsushi Takahashi, Takeshi Maehana, Toshiaki Tanaka, Naoki Itoh, Naoya Masumori
Publikováno v:
Japanese Journal of Clinical Oncology. 48:934-941
Objectives The aim of this study was to evaluate the efficacy of neoadjuvant gemcitabine and cisplatin (GC) therapy for muscle-invasive bladder cancer (MIBC). Methods We retrospectively evaluated patients who underwent neoadjuvant GC therapy followed
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 65(10)
A 72-year-old man was referred to our hospital for examination of a right adrenal tumor incidentally found by computed tomography for close inspection of lumbago. The computed tomography scan and magnetic resonance imaging showed a 51×54×43 mm soli
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 64(10)
A 60-year-old man presented at our hospital with gross hematuria. He had been treated for nephrotic syndrome with cyclophosphamide and steroids since he was in his 20s. We detected diffuse hemorrhagic cystitis on cystoscopy and diagnosed him with cyc
Renal cell carcinoma (RCC) accounts for only 2–6 % of pediatric renal tumors. Chromophobe RCC is very rare in pediatric patients, with only a few cases reported. A 12-year-old girl who had abdominal and left flank pain visited the pediatric clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02fa03c38f3bad62a27a60e983b18273
https://europepmc.org/articles/PMC6498370/
https://europepmc.org/articles/PMC6498370/
Autor:
Okabe KO; Department of Urology, Sapporo Medical University, School of Medicine, Sapporo, Japan; kookabe0408@yahoo.co.jp.; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Terada N; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Shirakawa T; Department of Urology, Nichinan Prefectural Hospital, Nichinan, Japan., Onizuka C; Department of Urology, Nichinan Prefectural Hospital, Nichinan, Japan., Kimura T; Department of Urology, Nobeoka Prefectural Hospital, Nobeoka, Japan., Yamashita Y; Department of Urology, Nobeoka Prefectural Hospital, Nobeoka, Japan., Otuka I; Department of Urology, Fujimoto General Hospital, Miyakonojo, Japan., Ueno T; Department of Urology, Fujimoto General Hospital, Miyakonojo, Japan., Nagano M; Department of Urology, Fujimoto General Hospital, Miyakonojo, Japan., Takamori H; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Mukai S; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Kamoto T; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Publikováno v:
Anticancer research [Anticancer Res] 2022 Oct; Vol. 42 (10), pp. 4981-4987.